Roche Hit By Surprising Tecentriq Miss In TNBC

Has Improved Survival With Nab-Paclitaxel But Not With Paclitaxel

 
• By Kevin Grogan
Roche tower
Roche HQ: Will Swiss major rue IMpassion131 study miss? • Source: Shutterstock

More from Clinical Trials

More from R&D